Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 4,400 shares at $16.01 ($71K) on 2023-03-30, disclosed to the SEC on 2023-04-03.
Scheduled sale ($71k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 2,000 | $32K | 45.3% |
| 2 | $16.00 | 400 | $6K | 9.0% |
| 3 | $16.16 | 2,000 | $32K | 45.7% |
| Total | $16.08 avg | 4,400 | $71K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |